Albemarle Corporation
Albemarle Completes Sale of Majority Stake in Ketjen to KPS Capital Partners
Summary
On March 2, 2026, Albemarle Corporation completed the sale of its 51% ownership interests in Ketjen Corporation to affiliates of KPS Capital Partners LP for approximately $547 million. Albemarle retains a 49% minority stake in Ketjen and 100% ownership of Ketjen's Performance Catalyst Solutions business. The sale, combined with the January 2026 sale of a 50% interest in the Eurecat joint venture, generated total pre-tax proceeds of approximately $670 million, which Albemarle plans to use for debt reduction and other corporate purposes.
Get alerts for ALB
Be first to know when Albemarle Corporation files with the SEC.
Filing Categories
Advertisement
About Albemarle Corporation
Albemarle Corporation is a global leader in the chemical manufacturing industry, specializing in the production of lithium, bromine, and catalysts. As a significant player in the lithium market, Albemarle is integral to the rapidly growing electric vehicle (EV) sector, owing to lithium's essential role in battery production. The company's operations extend across diverse applications, from energy storage solutions to petroleum refining and the pharmaceuticals industry. By providing advanced materials and solutions, Albemarle plays a crucial role in enabling cleaner energy technologies and sustainable industrial practices. Headquartered in Charlotte, North Carolina, Albemarle operates on a global scale, with production facilities and research centers strategically located around the world. The company's commitment to innovation and sustainability ensures its continuous impact on emerging technologies, making it a crucial stakeholder in the transition towards more sustainable energy and advanced industrial processes. Albemarle's market significance is underscored by its strategic partnerships and global supply chains that support some of the most dynamic and essential sectors in today's economy.
Official SEC Documents
Advertisement